Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 28, 2020

SELL
$72.34 - $84.0 $2.06 Million - $2.39 Million
-28,434 Closed
0 $0
Q2 2019

Jul 29, 2019

BUY
$61.87 - $69.38 $1.76 Million - $1.97 Million
28,434 New
28,434 $1.92 Million
Q1 2019

May 13, 2019

SELL
$62.53 - $70.05 $1.78 Million - $1.99 Million
-28,434 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$72.84 - $88.8 $932,716 - $1.14 Million
12,805 Added 81.93%
28,434 $2.1 Million
Q4 2017

Feb 05, 2018

BUY
$71.15 - $83.52 $1.11 Million - $1.31 Million
15,629
15,629 $1.12 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD Portfolio

Follow Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD, based on Form 13F filings with the SEC.

News

Stay updated on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD with notifications on news.